scPharmaceuticals Inc
SCPH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$302.2M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $302.20 Million |
|---|---|
| Enterprise Value | $314.82 Million |
| Earnings per Share | $-1.91 |
| Beta | 0.3 |
| Outstanding Shares | 53,719,662 |
Return
| Return on Equity | 430.27% |
|---|---|
| Return on Assets | -114.28% |
| Return on Invested Capital | -112.90% |
Valuation & Multiples
| P/E Ratio | -2.97 |
|---|---|
| PEG | -54.32 |
| Price to Sales | - |
| Price to Book Ratio | -5.67 |
| Enterprise Value to Revenue | 6.3 |
| Enterprise Value to EBIT | -4.66 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | -2.51 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 12, 2025
EPS Estimate
$-0.25
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.21, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.2069▲ 20.69% |
|---|---|
| Total Calls | 835,200▲ 10.36% |
| Total Puts | 172,800▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 76.24%▲ 5.14% |
|---|---|
| Total Invested | $232.21M▲ 59.55% |
| Investors Holding | 117▲ 16.00% |
About scPharmaceuticals Inc
CEO: John Tucker
